Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy

International Journal of Cardiology

Volumn 229, Issue , 2017, Pages 17-18

  Kountouras, Jannis ^a   Polyzos, Stergios A ^a   Katsinelos, Panagiotis ^a   Zeglinas, Christos ^a   Artemaki, Fotini ^a   Tzivras, Dimitri ^a   Vardaka, Elizabeth ^a   Gavalas, Emmanouel ^a   Romiopoulos, Iordanis ^a   Simeonidou, Constantina ^a   Grigoriadis, Nikolaos ^a   Kountouras, Constantinos ^a   Dardiotis, Efthimios ^a   Deretzi, Georgia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cardiovascular disease; Eradication therapy; Fibrinogen; Helicobacter pylori; Metabolic syndrome

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ANTIINFECTIVE AGENT;

ABDOMINAL OBESITY; BIOCHEMISTRY; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; ERADICATION THERAPY; HEALTH CARE SYSTEM; HELICOBACTER INFECTION; HUMAN; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; DRUG EFFECTS; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES;

ANTI-BACTERIAL AGENTS; CARDIOVASCULAR DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVENTIVE MEDICINE; RISK FACTORS;

EID: 85007189985     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.265     Document Type: Letter

References (10)

1. [1] Zuin, M., Rigatelli, G., Del Favero, G., Picariello, C., Meggiato, T., Conte, L., Faggian, G., Zuliani, G., Roncon, L., Coronary artery disease and Helicobacter pylori infection: should we consider eradication therapy as cardiovascular prevention strategy?. Int. J. Cardiol. 223 (2016), 711–712.
2. [2] Kountouras, J., Polyzos, S.A., Zavos, C., Deretzi, G., Kountouras, C., Vardaka, E., Katsinelos, P., Tsiaousi, E., Grigoriadis, N., Romiopoulos, I., Tzilves, D., Giartza-Taxidou, E., Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors. Hepatology 60 (2014), 1450–1451.
3. [3] Kountouras, J., Polyzos, S.A., Zeglinas, C., Katsinelos, P., Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease. Liver Int., May 13 2016, 10.1111/liv.13161.
4. [4] Franceschi, F., Gasbarrini, A., Polyzos, S.A., Kountouras, J., Extragastric diseases and Helicobacter pylori. Helicobacter(Suppl. 1), 2015, 40–46.
5. [5] Polyzos, S.A., Kountouras, J., Zavos, C., Deretzi, G., The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 16 (2011), 79–88.
6. [6] Kountouras, J., Polyzos, S.A., Deretzi, G., Katsinelos, P., Kyriakou, P., Helicobacter pylori infection and the risk for cardiovascular disease. Eur. J. Intern. Med. 22 (2011), e146–e147.
7. [7] Polyzos, S.A., Kountouras, J., Papatheodorou, A., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., Zavos, C., Anastasiadou, K., Terpos, E., Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 62 (2013), 121–126.
8. [8] Han, S.J., Ha, K.H., Jeon, J.Y., Kim, H.J., Lee, K.W., Kim, D.J., Impact of cadmium exposure on the association between lipopolysaccharide and metabolic syndrome. Int. J. Environ. Res. Public Health 9 (2015), 11396–11409.
9. [9] Kowalski, M., Pawlik, M., Konturek, J.W., Konturek, S.J., Helicobacter pylori infection in coronary artery disease. J. Physiol. Pharmacol. 57 (2006), 101–111.
10. [10] Lai, H.C., Chien, W.C., Chung, C.H., Lee, W.L., Wu, T.J., Wang, K.Y., Liu, C.N., Liu, T.J., Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: a population-based cohort study. Int. J. Cardiol. 223 (2016), 829–837.